Where does Clearside Biomedical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Clearside Biomedical, Inc. ranks #11,216 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Clearside Biomedical, Inc. hold?

Clearside Biomedical, Inc. holds 27 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Clearside Biomedical, Inc.'s Innovation Score?

Clearside Biomedical, Inc. has an Innovation Score of 44.1 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Clearside Biomedical, Inc.'s patent grant rate increasing or decreasing?

Clearside Biomedical, Inc.'s recent grant velocity is -15% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Clearside Biomedical, Inc.'s patents?

Clearside Biomedical, Inc.'s patents average 24.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Clearside Biomedical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Clearside Biomedical, Inc.

Q: What technology areas does Clearside Biomedical, Inc. focus on?

Clearside Biomedical, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 24 patents, ranking #299 of 3,490 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 27 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clearside ranks #11,216 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 10 technology areas.

#11,216
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.1/100): 24.6
avg claims per patent: -15%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11216 · US Corporation #11,216 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,216/49,997
PHOTO-FINISH Cembre S P A
CPC-FOCUS A61M · 10 areas
INNOV-PAR 44.1/100
CLAIMS-DENSE 24.6 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -15% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cembre S.P.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clearside’s 44.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (26%) Velocity 6.7 pts (15%) Breadth 11.2 pts (25%) Claim depth 14.8 pts (33%)

Qualcomm Incorporated · highest

85
Clearside Biomedical · this assignee

44
CyberArk Software · near

44
Public University… · near

44
Tachi-s · near

44
Tokai Optical · near

44
3D Lighting… · lowest

7

What this shows Clearside's Innovation Score is 44.1/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clearside?

Each dot is one of Clearside’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clearside’s own 24.6 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clearside vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clearside's grants concentrate

Clearside Biomedical, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 88.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2015. By volume, Clearside sits between Cembre S.P.A. and CPT Group GmbH.

Clearside's three-year grant acceleration

Clearside Biomedical, Inc. shows 7 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cembre S P A

27
Central Motor Whe…

27
Champ Vision Disp…

27
Chaoyang Semicond…

27
Co2pac

27
Cognyte Israel

27
Coperion

27
CPT Group

27
Clearside Biomedi… ◀

27

What this shows Clearside holds 27 patents at rank #11,204, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Clearside

By rank, the assignees closest to #11,204 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Clearside's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Clearside, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Clearside ranks #299 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Public University Corporation Yokohama City University 44 CyberArk Software Ltd. 44 Tachi-s Co., Ltd. 44 Tokai Optical Co., Ltd. 44

Clearside's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Clearside Biomedical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.7%
2016	1	3.7%
2017	5	18.5%
2018	3	11.1%
2019	3	11.1%
2020	2	7.4%
2021	2	7.4%
2023	3	11.1%
2024	4	14.8%
2025partial year	3	11.1%

Which technologies does Clearside Biomedical, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 24

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 20

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C07K - Peptides 4

A61B - DIAGNOSIS; SURGERY; Identification 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Clearside Biomedical, Inc.'s patent record in context - here's where to go next.

Clearside Biomedical, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 88.9% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #11,216 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Clearside Biomedical, Inc. against Cembre S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.